4 Medical Device Giants to Consider for AI-Driven Healthcare Investments
The demand for precision and personalized medicine is fueling the growth of artificial intelligence (AI) in medical devices. AI-enabled tools now support highly individualized diagnostics and treatments, making them a key focus for healthcare professionals and investors alike. For those looking to invest in major medical device companies leveraging AI, four standout names include Boston Scientific Corp. (BSX), Johnson & Johnson (JNJ), GE HealthCare Technologies Inc. (GEHC), and Tempus AI Inc. (TEM). Each of these companies carries a strong buy rating with a Zacks Rank #2.
Growing AI Integration in Medical Devices
Generative AI and agentic AI are increasingly embedded in medical devices worldwide. These technologies improve clinical workflows and patient care by analyzing imaging data, genetic profiles, and more. Generative AI is often used for content creation and design optimization, while agentic AI allows devices to operate autonomously based on real-time data.
Examples include AI-powered diagnostic tools that help design implants and surgical plans, as well as predictive maintenance systems for connected equipment like MRIs and ventilators. These applications enhance accuracy, efficiency, and patient outcomes.
Boston Scientific Corp.
Boston Scientific is performing well despite economic challenges such as tariff-related cost pressures. The company is investing heavily in AI to improve its devices and procedural results. Its MedSurg and Cardiovascular product lines are in high demand, with strong traction in the U.S. and international markets for its next-generation WATCHMAN FLX devices.
Key AI-powered technologies include HeartLogic, which detects worsening heart failure in patients with implantable devices, and the Rhythm AI module that automates interpretation of electroanatomical maps to improve arrhythmia treatments. The Coronary Advanced Analysis software uses AI to analyze imaging for plaque characterization.
Boston Scientific is expected to grow revenues by 18.3% and earnings by 18.7% this year, with recent upward revisions in earnings estimates.
Johnson & Johnson
Johnson & Johnson’s MedTech division focuses on surgical robotics, digital surgery analytics, and imaging, all underpinned by AI technologies. Its next-generation robotic platform, Ottava, and digital surgery systems like Caresurgical/VELYS use AI for procedure planning and surgical performance enhancement.
The Polyphonic Digital Ecosystem connects operating rooms to share live video and data, helping surgeons identify key events during procedures through AI analysis. This facilitates better collaboration and decision-making during surgery.
JNJ expects revenue growth of 5.2% and earnings growth of 8.8% this year, with stable recent earnings estimate revisions.
GE HealthCare Technologies
GE HealthCare Technologies benefits from rising procedure volumes and hospital investments globally. AI plays a central role in its precision care approach, including solutions like CleaRecon DL, which improves cone-beam CT image quality using AI.
The Invenia Automated Breast Ultrasound Premium offers advanced AI features that speed up supplemental breast cancer screenings and streamline exam readings, especially for patients with dense breast tissue.
GEHC forecasts revenue growth of 3.5% and earnings growth of 0.9% this year. Notably, earnings estimates have improved by 12.7% in the last month, signaling strong market confidence.
Tempus AI Inc.
Tempus AI focuses on precision medicine by applying AI to healthcare data. Its solutions support physicians with personalized patient care and aid in discovering and delivering optimal therapeutics, particularly in oncology and cardiology.
Tempus integrates diverse data types — phenotypic, morphologic, and molecular — to provide comprehensive patient insights. Its AI tools assist with clinical note generation, identifying care gaps, and treatment decisions.
Tempus is projected to grow revenues by 81.1% and earnings by 55.7% this year, with recent positive revisions in earnings forecasts.
Conclusion
Investing in medical device companies that prioritize AI applications offers exposure to a segment poised for growth due to increasing demand for personalized healthcare solutions. Boston Scientific, Johnson & Johnson, GE HealthCare Technologies, and Tempus AI present compelling opportunities backed by solid AI-driven innovation and improving financial outlooks.
For healthcare professionals interested in expanding their knowledge of AI in medical technology, exploring specialized AI training courses can be beneficial. Resources like Complete AI Training offer tailored programs to enhance skills relevant to healthcare AI applications.
Your membership also unlocks:
